3Okur FV,Oguz A,Karadeniz C,et al.Refractoriness to rituximab monotherapy in a child with relapsed/refarctory Burkitt non-Hodgkin lymphoma[J].Pediatr Hematolcol,2006,23(1):25. 被引量：1
5Otter R, Bieger R, Kluin P M, et al. The intemationa nonhodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma[J].N Engl J Med, 1993,329(5) : 987. 被引量：1
6Maloney D G, Smith B, Rose A. Rituximab: mechanism of action and resistance[J].Semin Onod,2002,29(1 Suppl 2):2- 9. 被引量：1
7Wilson W H,Gutierrez M O,Connor P,et al. The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a prelim inary report of dose adjusted EPOCH-R[J].Semin Oncol,2002 29(2):41-47. 被引量：1
8W. S. Kim,S.-Y. Song,Y. C. Ahn,Y.-H. Ko,C.-H. Baek,D. Y. Kim,S.-S. Yoon,H. G. Lee,W. K. Kang,H. J. Lee,C. H. Park,K. Park. CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?[J] 2001,Annals of Oncology(3):349～352 被引量：1
7Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neuro1,2005,58 (4) :594-604. 被引量：1
8Dalmau J, Ttlztin E, Wu, HY, et al. Paraneoplastic anti-N- methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol,2007,61 ( 1 ) :25-36. 被引量：1
9Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neuro sci, 2010,30(17) :5866-5875. 被引量：1
10Sansing LH, Ttizan E, Ko MW, et al. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neuro1,2007,3 ( 5 ) :291-296. 被引量：1
